ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

A novel dihydroisoxazole derivative DHI9 suppresses colorectal cancer cell survival by inducing oxidative stress, DNA damage, and mitochondrial apoptosis while targeting Akt and Wnt/β-catenin signalling.

Simona Zilakova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.